Vysis
by Abbott Molecular Inc. 9 variants
Ref 08N85-085
Vysis (08N85-085) is a Class A device made by Abbott Molecular, registered in EUDAMED on 5 Nov 2026 (Basic UDI-DI 0884999VyN0885T9), active as of 7 Nov 2026.
Active
CE IVDR
Valid until
No date given
FDA recalls
Not applicable
Documents
None, self-declared
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| European Union | CE/IVDR | Number0884999VyN0885T9 00884999046849 | Date5 Nov 2026 | StatusActive |
Official records
- EUDAMED public site 0884999VyN0885T9
Certificates
No certifier certificate is listed. Devices of this class are self-declared by the manufacturer.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
European Union — CE/IVDR Active
Specification
- Device name
- Vysis Intellifish Universal Ffpe Tissue Pretreatment Protease Kits and Wash Reagent Kit
- Model / reference
- 08N85-085
- Primary DI / UDI-DI
- 00884999046849
- Basic UDI-DI
- 0884999VyN0885T9
- EMDN code
- W01030799 Histology / cytology reagents - other
- Device class
- Class A
- EU registration type
- Standard device
- EU market of registration
- Germany
Manufacturer details
- EUDAMED SRN
- US-MF-000017776
- Authorised representative
- Abbott GmbH DE-AR-000009457
Similar devices in this category
Other devices filed under HISTOLOGY / CYTOLOGY REAGENTS - OTHER.
- master diagnóstica MAD-PCLKBC by VITRO, S.A.
- Phosphate Buffered Saline R1032-052 by Lumatas Biosystems, Inc.
- Buffer Solution LTC120111 by Hunan Lituo Biotechnology Co., Ltd.
- Immunohistochemical Antigen Retrieval Buffer DMRD2049 by Shenzhen Dartmon Biotechnology Co., Ltd.
- master diagnóstica MAD-004079VS by VITRO, S.A.
- Novocastra Streptavidin-HRP RE7104 by Leica Biosystems Newcastle, Limited
- 6-FAM Antibody DMRD0594 by Shenzhen Dartmon Biotechnology Co., Ltd.
- Diagnostic BioSystems K023 by Diagnostic BioSystems
- Immersion Oil 20ml by Baso Diagnostics Inc. Zhuhai
- Cell Preservation Vial FCA01-JA by Hangzhou HealthSky Biotechnology Co., Ltd.